Press Releases

Date Title and Summary Additional Formats
Toggle Summary Anthera Pharmaceuticals Announces Completion of Dosing in CHABLIS-SC1 Phase 3 Clinical Study with Blisibimod View HTML
Toggle Summary Anthera Provides Clinical Program Updates for Blisibimod and Sollpura® View HTML
Toggle Summary Anthera Pharmaceuticals Announces Presentation at JMP Securities Life Sciences Conference View HTML
Toggle Summary Anthera Pharmaceuticals Announces Presentation at Jefferies Healthcare Conference View HTML
Toggle Summary Anthera Pharmaceuticals Provides Business Update and Reports 2016 First Quarter Financial Results View HTML
Toggle Summary Anthera Pharmaceuticals Appoints Brent Furse to Board of Directors View HTML
Toggle Summary Anthera Pharmaceuticals Provides Business Update and Reports 2015 Fourth Quarter and Fiscal Year Financial Results View HTML
Toggle Summary Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer View HTML
Toggle Summary Anthera Pharmaceuticals Announces Appointment of Craig Thompson as President and Chief Operating Officer and Dr. Chuck Olson as Chief Technology Officer View HTML
Toggle Summary Anthera Pharmaceuticals Provides Business Update and Reports Third Quarter 2015 Financial Results View HTML